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Four female patients with euthyroid Graves' disease Group I (Liddle, et al., 1965) were investigated. All those patients had diffuse goiter and eye signs of Graves' disease. They all had no history or clinical evidence of hyperthyroidism.
Serum total thyroxine (T4) was measured with the method described by Murphy and 131 I_triiodo-thyronine resine sponge uptake (131 I-T3-RSU) with Triosorb (Dainabot Laboratories, Tokyo). Serum T3 concentration was measured with the radioimmunoassay by Sephadex G25 column recently developed in our laboratory (Shimizu, et al., 1973 (Shishiba, et al., 1973) .
Results and Discussion Table 1 summarizes the data obtained in four patients with euthyroid Graves' disease. As shown, all the patients had goiter and eye signs of Graves' disease. Their normal T4, T3-RSU, failure of suppression of thyroidal radioiodine uptake by T3 and their lack of history of hyperthyroidism indicate that the patients under study belonged in euthyroid Graves' disease Group I (Liddle, et al., 1965) . Three of the patients were tested for TRHinduced TSH increase. All showed no elevation of TSH. In all four patients, T3 concentration measured by radioimmunoassay was within normal limits. Anti-thyroglobulin antibody measured by hemagglutination and LATS activity by McKenzie assay were negative in all four patients..
Relevant to the present findings, Lawton reported the normal T3 concentration and TRH-refractoriness in two patients with euthyroid Graves' disease. However, one of his patients had an overt history of hyperthyroidism and received thyroidectomy. In the other patient, eye signs were not described. Thus, his study mainly dealt with euthyroid Graves' disease Group II (Lawton, et al., 1971 
